Tukavo 50mg Tablet
By Zydus Lifesciences Ltd
50mg
Tukavo 50 mg Tablet is a prescription medicine manufactured by Zydus Lifesciences Ltd. It is used in the treatment of advanced or metastatic HER2-positive breast cancer, especially in patients who have previously been treated with other HER2-directed therapies. This medicine is commonly prescribed in combination with trastuzumab and capecitabine. Tukavo contains tucatinib, a highly selective tyrosine kinase inhibitor that targets the HER2 receptor. It works by blocking the signals that promote the growth and spread of cancer cells. Tukavo is particularly effective in patients with brain metastases, as it can cross the blood-brain barrier and help manage central nervous system involvement. At Macarius Health, we ensure timely access to Tukavo 50 mg at competitive prices, so patients can benefit from cutting-edge treatments without compromise.
Price
₹17,920.00
₹21,145.00
Save 15% off MRP
All prices are inclusive of taxes. Final commercial terms are confirmed on quote.
Dosage
50mg
Pack Size
1 Bottle of 60 Tablets
Active Ingredient / Salt
Tucatinib
Product Description
Tukavo 50 mg Tablet is a prescription medicine manufactured by Zydus Lifesciences Ltd. It is used in the treatment of advanced or metastatic HER2-positive breast cancer, especially in patients who have previously been treated with other HER2-directed therapies. This medicine is commonly prescribed in combination with trastuzumab and capecitabine. Tukavo contains tucatinib, a highly selective tyrosine kinase inhibitor that targets the HER2 receptor. It works by blocking the signals that promote the growth and spread of cancer cells. Tukavo is particularly effective in patients with brain metastases, as it can cross the blood-brain barrier and help manage central nervous system involvement. At Macarius Health, we ensure timely access to Tukavo 50 mg at competitive prices, so patients can benefit from cutting-edge treatments without compromise.
Product Info
- Price
- ₹17,920.00
- MRP
- ₹21,145.00
- Dosage
- 50mg
- Pack Size
- 1 Bottle of 60 Tablets
- Manufacturer
- Zydus Lifesciences Ltd
- Active Ingredient
- Tucatinib
- Category
- Oncology
Key Benefits
- Controls progression of HER2-positive advanced breast cancer
- Effective in treating patients with brain metastases
- Improves survival outcomes when used in combination therapy
- Can be taken orally at home under medical supervision
- Trusted by oncologists across India for its targeted mechanism
Usage & Safety
Direction for Use
* For oral use only * Swallow whole with water, with or without food, as directed by your doctor * Do not crush or chew the tablet * Follow your oncologist’s dosing schedule strictly
Safety Information
* Not recommended during pregnancy or breastfeeding * Use effective contraception during treatment and for a few weeks after * Regular monitoring of liver function and complete blood counts is advised * Avoid alcohol and smoking during treatment * Contact your doctor immediately if you experience symptoms like jaundice, severe diarrhea, or unusual fatigue * Keep out of reach of children
Allergy Information
* May contain excipients like lactose or microcrystalline cellulose * Do not use if allergic to tucatinib or similar agents
Good to Know
* Manufactured in WHO-GMP certified facility * Storage: Store below 30°C in a dry place away from sunlight * Prescription required * May be available under oncology access programs in select regions
Why Choose Tukavo 50mg Tablet?
Authentic Product
We source Tukavo 50mg Tablet through trusted pharmaceutical channels with an emphasis on authenticity and batch traceability.
Quality Control
Rigorous handling, compliant storage, and careful dispatch planning help protect product integrity.
Fast Delivery
Institutional quote handling and lane planning keep urgent requirements moving without avoidable delays.
Expert Support
Our team helps align pack, category, and procurement details before you finalize a commercial decision.
Special Benefit Schemes
- Trastuzumab and Capecitabine are provided free as per the requirements of the prescription under the Patient Assistance Program (PAP).
- For eligibility details
- latest updates
- and enrollment process
- please contact us directly.
Alternative Medicines with Same Salt
These alternatives share the same active ingredient or linked molecule record. Please consult your healthcare provider before making any substitutions.
Same salt alternative
Intuca 150mg Tablet
By Intas pharmaceutical pvt ltd · 150mg
Intuca 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of HE…
₹4,980.00 /strip
View details
Same salt alternative
Tucaliv 150mg Tablet
HETERO HEALTHCARE PVT LTD · 150mg
Tucaliv 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of H…
₹24,880.00 /bottle
View details
Same salt alternative
Tucanat 150mg Tablet
Natco Pharma Ltd · 150mg
Tucanat 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of H…
₹28,100.00 /bottle
View detailsRelated Oncology Products
Explore other products from the same category.
Oncology
Intuca 150mg Tablet
By Intas pharmaceutical pvt ltd · 150mg
Intuca 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of HE…
₹4,980.00 /strip
View detailsMore from Zydus Lifesciences Ltd
Explore other products from the same trusted manufacturer.
Zydus Lifesciences Ltd
Tukavo 150mg Tablet
Zydus Lifesciences Ltd · 150mg
Tukavo 150mg contains Tucatinib, a tyrosine kinase inhibitor used in the treatment of HER2-positive breast cancer. It i…
₹29,195.00 /bottle
View detailsReady to Order Tukavo 50mg Tablet?
Get competitive pricing, institutional support, and confirmed availability for Tukavo 50mg Tablet. Share quantity, location, and timeline and our team will respond with the right next step.